Physician profile
Robert S Hix
NPI 1720053903
$3,308.53
in general payments reported to CMS, 2019-2025
32 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $307 · 2021: $1,037 · 2022: $904 · 2023: $303 · 2024: $309 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,080.12 | 2019-2023 | |
| Pfizer INC. | $216.97 | 2019-2024 | |
| Caldera Medical, INC | $214.12 | 2022-2023 | Desara |
| Organon LLC | $162.13 | 2021-2025 | Nexplanon, Jada System |
| Gynesonics, INC. | $156.62 | 2021 | |
| Exeltis, USA INC. | $156.58 | 2021-2024 | Slynd |
| Hologic Sales and Service, LLC | $141.17 | 2021-2024 | Myosure Tissue Removal Device, Aptima, Novasure |
| Astellas Pharma US INC | $135.76 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $106.84 | 2021-2023 | |
| Baxter Healthcare | $97.69 | 2022 | |
| Medtronic, INC. | $96.74 | 2021-2024 | Interstim, Ligasure |
| Coloplast Corp | $92.13 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $83.03 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.02 | 2020-2023 | |
| Applied Medical Resources Corporation | $67.23 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $51.73 | 2025 | Zurzuvae |
| Millicent US INC | $48.02 | 2025 | Intrarosa, Femlyv |
| Myovant Sciences INC. | $46.63 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $34.63 | 2021 | |
| Scynexis, INC. | $30.30 | 2022 | |
| Minerva Surgical, INC | $28.46 | 2024 | |
| Meditrina | $26.37 | 2022-2024 | |
| Therapeuticsmd, INC. | $25.95 | 2019 | |
| Covidien LP | $22.01 | 2020 | |
| Coopersurgical, INC. | $20.05 | 2021 | |
| Medline Industries LP | $15.73 | 2022 | |
| Urovant Sciences INC | $15.13 | 2021 | |
| Convatec INC. | $14.29 | 2020 | |
| Boston Scientific Corporation | $13.75 | 2020 | |
| Novo Nordisk INC | $13.32 | 2020 | |
| Eisai INC. | $11.06 | 2021 | |
| Merck Sharp & Dohme LLC | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.